Skip to main content

Table 1 Clinical characteristics of the 142 CHC patients in this study

From: LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients

 

CHC patients with serum and plasma specimens (n = 97)

CHC patients treated with IFN and achieved RVR (n = 45)

Age (year)

52.30 ± 8.20

52.64 ± 7.49

Gender (male/female)

55/42

30/15

TBIL (μmol/L)

16.90 ± 7.40

/

DBIL (μmol/L)

7.47 ± 3.14

/

ALP (U/L)

88.41 ± 31.01

/

GGT (U/L)

79.79 ± 91.21

/

ALT (U/L)

57.88 ± 50.87

119.71 ± 110.95

AST (U/L)

45.50 ± 32.49

87.70 ± 82.70

PLT (×109/L)

189.07 ± 66.50

166.60 ± 83.20

FibroScan

9.44 ± 10.22

15.16 ± 7.63

MAL/DSA

Serum: 10.01 ± 1.94

9.29 ± 2.39

Plasma: 10.35 ± 2.30

AOL/DSA

Serum: 3.02 ± 3.43

6.34 ± 7.33

Plasma: 3.57 ± 4.78